MRK · XBRL financial data
Merck financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (MRK's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 47,994 | 48,704 | 59,283 | 60,115 | 64,168 | 65,011 |
| Cost of goods and services sold | 15,485 | 13,626 | 17,411 | 16,126 | 15,193 | 16,382 |
| Research and development | 13,558 | 12,245 | 13,548 | 30,531 | 17,938 | 15,789 |
| Selling, general and administrative | 10,468 | 9,634 | 10,042 | 10,504 | 10,816 | 10,733 |
| Interest income | 59 | 36 | 157 | 365 | 415 | 343 |
| Interest expense | 831 | 806 | 962 | 1,146 | 1,271 | 1,357 |
| Other income (expense) | 886 | 1,341 | (1,501) | (466) | 24 | (151) |
| Income tax expense (benefit) | 1,709 | 1,521 | 1,918 | 1,512 | 2,803 | 2,804 |
| Net income (loss) | 7,067 | 13,049 | 14,519 | 365 | 17,117 | 18,254 |
| Earnings per share, basic USD per share | 2.79 | 5.16 | 5.73 | 0.14 | 6.76 | 7.30 |
| Earnings per share, diluted USD per share | 2.78 | 5.14 | 5.71 | 0.14 | 6.74 | 7.28 |
| Weighted average shares, basic millions of shares | 2,530 | 2,530 | 2,532 | 2,537 | 2,532 | 2,502 |
| Weighted average shares, diluted millions of shares | 2,541 | 2,538 | 2,542 | 2,547 | 2,541 | 2,507 |
Balance sheet
CSVFiscal years (MRK's year ends in late December)
Cash flows
CSVFiscal years (MRK's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | 7,067 | 13,049 | 14,519 | 365 | 17,117 | 18,254 |
| Stock-based compensation | 475 | 479 | 541 | 645 | 761 | 820 |
| Net cash from operating activities | 10,253 | — | 19,095 | 13,006 | 21,468 | 16,472 |
| Purchases of property and equipment | — | 4,448 | 4,388 | 3,863 | 3,372 | 4,112 |
| Net cash from investing activities | (9,443) | — | (4,960) | (14,083) | (7,734) | (13,741) |
| Share repurchases | 1,281 | 840 | 0 | 1,346 | 1,306 | 5,084 |
| Dividends paid | 6,215 | 6,610 | 7,012 | 7,445 | 7,840 | 8,176 |
| Proceeds from long-term debt | 4,419 | 7,936 | 0 | 5,939 | — | — |
| Repayments of long-term debt | 1,957 | 2,319 | 2,251 | 1,755 | 1,290 | 2,503 |
| Net cash from financing activities | (2,832) | — | (9,119) | (4,810) | (7,032) | (1,922) |
| Net change in cash | (1,769) | 14 | 4,606 | (5,864) | 6,409 | 1,372 |
Compare with peers
The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.
Not investment advice. Not affiliated with the U.S. SEC.